Monday, December 18, 2006
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
PR Newswire - SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder -- WILMINGTON, Del., Oct. 20 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced
Source: sev.prnewswire.com
Click here for more information about depression diet depression diet
